Malaysia
Search
Sign In
Change Password
Points
Sign Out
Neurology
Top Medical News
Among patients with pharmacoresistant epilepsy who underwent surgery, those with an incomplete resection of a magnetic resonance imaging‐defined cortical lesion are at risk of late seizure recurrence, as shown in a study.
Results of a small single-arm study in Canada suggest that low-dose ionizing radiation (LDIR) may be a promising therapy for Alzheimer’s disease (AD).
After more than three decades of follow-up, a prospective cohort study of nearly 9,000 men finds dissatisfaction with married life to be associated with increased long-term risk of stroke and all-cause mortality.
Persistently short sleep during midlife appears to exacerbate the risk of dementia in old age, a recent study has found.
Low baseline levels of serum neurofilament light chains (sNfL) may help identify multiple sclerosis (MS) patients who are likely to optimally respond to dimethyl fumarate (DMF) treatment, a recent study has found.
An investigational transdermal amphetamine patch worn for 9 hours on the hip appeared effective in paediatric patients with attention deficit-hyperactivity disorder (ADHD) in a phase II, two-part trial.
Not only does the CGRP* inhibitor galcanezumab show sustained efficacy in migraine patients, long-term treatment does not come with excess cardiovascular (CV) risk, according to studies presented at the AAN 2021 Annual Meeting.
Special Reports
Multiple sclerosis (MS) is one of the most common neurological disorders – affecting over 2.3 million people globally – and it is the leading cause of nontraumatic disability in young adults. However,the availability of supportive resources and services for people with MS is scarce in many regions of the world. In Malaysia, the prevalence of MS is estimated at 2-3/100,000; the current Malaysian clinical practice guidelines on the management of MS recommend disease modifying agents, such as interferon-β and teriflunomide, as first-line therapeutic agents. In this article, Dr Singer - in partnership with Sanofi and the Malaysian Society of Neurosciences - shares his insights into managing MS dynamically, highlighting the importance of early intervention in improving patient outcomes.
Conference Reports
Not only does the CGRP* inhibitor galcanezumab show sustained efficacy in migraine patients, long-term treatment does not come with excess cardiovascular (CV) risk, according to studies presented at the AAN 2021 Annual Meeting.
Individuals with depression or anxiety showed earlier onset of Alzheimer's disease (AD) by 2–3 years compared with those without these psychiatric disorders, according to a study presented at the AAN 2021 Meeting — suggesting that patients with symptoms of depression or anxiety should be monitored for cognitive complaints.
The risk of depression following a stroke may be greater in women than men, according to a retrospective study from the US presented at ISC 2021.
Outcomes after stroke thrombectomy were no better with tissue plasminogen activator (tPA) withheld in the MR CLEAN-NO IV trial, suggesting that the practice of giving thrombolytics still holds in stroke.
Stroke survivors may be at an elevated risk of suicide attempts and deaths, according to results of a systematic review and meta-analysis.
Silent myocardial infarction (MI) or heart attack appears to be associated with an increased risk of stroke in older adults, according to a study presented at ISC 2021.
Select stroke patients who present late to the hospital — beyond 6 hours and up to 24 hours after stroke onset — still stand to benefit from endovascular thrombectomy, confirms the AURORA meta-analysis of six randomized trials presented at the ISC 2021 Meeting.